// App-Quantinova.ai

TCT-545 : The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after drug-eluting stent implantation

Researchers

Presenter

  • Tahei Ichinohe

Principal Investigators

  • Kazushige Kadota

  • Haruki Eguchi

  • Kazuaki Mitsudo

  • Seiji Habara

  • Hiroyuki Tanaka

  • Takeshi Tada

  • Yasushi Fuku

  • Naoki Oka

  • Hiroyuki Yamamoto

  • Satoki Fujii

  • Tsuyoshi Goto

Medical Centers

  • Kurashiki Central Hospital, Kurashiki, Japan

  • Kurashiki Central Hospital, Okayama-ken Kurashiki-shi, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved